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Summary 
Systemic autoimmune diseases  are frequently associated with clustering of high titer autoanti- 
body responses towards  nuclear  self-antigens.  Little is known,  however, about the  extent of 
immune tolerance to the target nuclear antigens or the events leading to the complex autoanti- 
body responses that are characteristic  of systemic autoimmunity.  To address these  issues,  we 
have examined the mouse immune response to La autoantigen (mLa) and the homologous hu- 
man La antigen  (hLa),  which  are  components of the  La(SS-B)/Ro(SS-A)  ribonucleoprotein 
(RNP)  complex targeted  in  systemic lupus  erythematosus and primary Sj6gren's  syndrome. 
The findings reveal the presence of hierarchical T  cell tolerance involving multiple autodeter- 
minants within the La autoantigen expressed by normal H-2  k and H-2  a mice. At one end of 
this spectrum, there was no detectable T  or B  cell autoimmunity observed in mice that were 
immunized with the immunodominant mLa28v 301 determinant, which differed by a single resi- 
due in its core sequence from the homologous but highly immunogenic human La288-302 deter- 
minant.  Interestingly, the mLa287_301 peptide acted as an altered pepude ligand that specifically 
antagonized the activation of an hLa288_302-specific T  cell hybridoma. In contrast to the tolero- 
genic mLa287_301 determinant,  a range of autoimmune potential was identified among poorly 
tolerizing, subdominant self-peptides present within mouse La autoantigen. Notably, immuni- 
zation of normal mice with the autologous subdominant La25_44 and La106_12  ~ determinants re- 
sulted in hmited or no detectable autoantibody response.  In contrast,  immunization with the 
subdominant mouse La13_30 determinant induced a proliferative T  cell response associated with 
the appearance of specific autoantibodies recognizing multiple intrastructural (La) and intermo- 
lecular components (Ro) of the murine La/Ro RNP. The findings suggest how diversified au- 
toimmunity might follow initiation  of immunity to simple peptide  mimics of poorly tolero- 
genic determinants that are present within ubiquitous self-antigens. 
A 
key feature of many systemic autoimrnune diseases is the 
presence of high titer autoantibodies that recognize ubiq- 
uitously expressed nuclear or cytoplasmic self-antigens.  These 
autoantibodies are relatively disease specific and often recog- 
nize multiple components of discrete subcellular particles (1). 
For  instance,  autoantibodies  that  recognize  nucleosomes, 
double-stranded  DNA,  and  small  nuclear  ribonucleopro- 
teins (snRNPs) 1 are characteristic of SLE, whereas antibod- 
ies that recognize components of the Ro (SS-A)/La (SS-B) 
1Abbreviations used in this paper: aa, amino acid; GST, glutathlone S-trans- 
ferase; 6xHls, 6x-hlsudme; HEL, hen egg lysozyme;  hLa, human La anti- 
gen; LIA, I-Ak-transfected  L cells; mLa, mouse La anUgen; PPD, purified 
protein denvauve. SI, snmulanon index; SnRNP, small nuclear ribonu- 
cleoprotems. 
RNP are most commonly associated  with primary Sj6gren's 
syndrome.  Clustering  of autoantibody responses probably 
reflects the physical association of the various target struc- 
tures within distinct subcellular particles (1-3). This notion 
is  supported  by  experiments  that  show  spreading  of au- 
toimmunity towards the different components of the Ulsn 
RNP  (1,  4,  5)  and the Ro/La RNP  (6)  after initiation of 
immunity to a single component of either complex. 
We have previously shown that molecular spreading of 
immunity to the Ro/La RNP complex can be induced in 
normal  mice  by  immunization  with  a  single  107-amino 
acid  (aa) fragment  of the  autologous  La polypeptide  (6). 
These  observations suggest that immune tolerance  to  nu- 
clear self-antigens may be absent or incomplete, suggesting 
a degree of immune ignorance even in normal individuals. 
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may be naturally triggered by the initiation ofT helper im- 
munity. Incomplete self-tolerance to sequestered self-anti- 
gen is described in some models of tissue-specific autoim- 
munity where nontolerogenic cryptic peptides are believed 
to play an important role in driving autoreactive T  cells and 
antibody diversification (7-10).  There is also some evidence 
that nontolerogenic determinants exist in ubiquitously dis- 
tributed self-components (11-16)  including nuclear/cyto- 
plasmic antigens targeted in systemic auto~mmunity (1,  4, 
17,  18).  However, the precise extent to which the helper 
T  cell compartment is tolerized to nuclear/cytoplasrmc  an- 
tigens is  not  known,  and the  general nature  of the  self- 
determinants recognized by T  helper cells in systemic au- 
toimmunity is unclear. 
We now show that healthy normal mice are tolerant to 
immunodominant  T  helper epltopes that are present within 
the La polypeptide of the La/Ro P,.NP. Nonetheless, T  cells 
from the  same  mice  can react  to  subdominant or  cryptic 
determinants of La protein after autoimmunization. More- 
over,  our data  demonstrate that  experimental autoimmu- 
nity involving multiple intrastructural and  intermolecular 
components of the Ro/La RNP  complex can be induced 
in normal mice  that  have been immunized with  a  single 
subdominant or cryptic peptide derived from the La pro- 
tein.  These  observations reveal  how  autoimmunity to  a 
simple peptide determinant can lead to complex autoanti- 
body patterns through intra- and intermolecular spreading. 
In  addition,  the  findings suggest  how  limited molecular 
mimicry of a  single antigenic region of a  ubiquitous au- 
toantigen might initiate spreading of systemic autoimmune 
responses through activation of poorly tolerized autoreac- 
tive T  cells. 
Materials  and Methods 
Protein Antigens.  Recombinant mouse La  (mLa), human La 
(hLa), human R.o 60 (htLo 60), mouse Ro 52 (mRo 52), and hen 
egg  lysozyme  (HEL)  were  produced  in bactena as  6-hisndine 
(6xH1s) fusmn proteins expressed in Escherichia coli from the vec- 
tor pQE (QIAGEN, Inc., Chatsworth, CA). Alternatively,  these 
proteins were expressed as glutathlone S-transferase (GST) fusion 
proteins from  the  pGEX-2T bacterial  plasmid  vector  (Amrad, 
Melbourne, Austraha).  6xHis-hLa was  also expressed  in insect 
cells infected with fe~combinant baculovirus,  and was kindly sup- 
phed by Dr. Nell Cook (Ehas, Freiburg, Germany). Subfragments 
ofmLa and hLa were expressed as GST fusion proteins as described 
previously (19, 20). Bacterial recombinant proteins were purified 
by either metal chelate affinity chromatography (Ni-NTA affinity 
chromatography)  (21) or  glutathione  affinity  chromatography 
(22). Recombinant proteins were passed through an endotoxin 
column (Pierce,  Chemical Co., Rockford, IL) to remove bacte- 
rial endotoxins potentially contaminating  the preparations. 
Native and recombinant La antigen is known to be sensitive to 
proteolysis  (23,  24),  and mass spectrometric  analysis of purified 
recombinant 6xHls-La  antigens indicated that  the  majority of 
bactenal recombinant La proteins possessed a molecular mass of 
,-43 kD instead of the predicted 48 kD. This discrepancy in mo- 
lecular mass is presumed to reflect bacterial proteolysis associated 
with  protease-sensltive  PEST  regions  of  La  (23-26).  When 
6xHis-hLa was produced in the  baculovirus expression  system, 
the resultant La protein was full length, as judged by its mol mass 
of`"48 kD after SDS-PAGE. Accordingly, baculovirus recombi- 
nant La protein was used in several immunizations to complete 
the T cell epltope mapping of the munne immune response to hLa. 
Peptides.  For initial screening of peptide specificity of lymph 
node T cells, a set of 155 overlapping 15-mer peptides ofhLa was 
synthesized by the multlpin synthesis system (Chiron Mimotopes, 
Clayton, Australia; 27)  using optimized F-moc-based chemistry 
(28, 29) so that peptides could be cleaved from the pins. Peptides 
were  dissolved  in DMSO  at  ~1  mM  concentration. Pepndes 
spanned the  complete  length  of the  La  molecule  sequentially 
shifting by 2 or 3 amino acids, giving a 13-12-aa overlap of adja- 
cent peptides.  The peptIdes  hLa 288-302, mLa 287-301,  13-30, 
25-44,  106-129,  and HEL 46-61  were synthesized  on an auto- 
mated  peptide  synthesizer  (model  431A;  Applied  Blosystems, 
Inc., Foster City, CA) using both t-Boc-and F-moc-based chem- 
istries, and were subsequently purified by reverse  phase  HPLC. 
The peptides  were analyzed and their masses were confirmed by 
electrospray  1onisation mass spectrometry using a triple  quadru- 
pole  mass spectrometer  (AP  III;  Perkin Elmer-Sciex,  Ontario, 
Canada).  The mLa amino acid sequence contains a single amino 
acid  deletion at  the position corresponding to  hLa  residue  217 
and a 16-aa insertion after position 332, which changes the num- 
bering of some mLa peptides relative to their hLa equivalent (30). 
Immunization.  6-8-wk-old female A/J (H-2  ~) and CBA/CaH 
(H-2  k) mice were purchased  from the Animal Resource Centre 
(Perth,  Australia) and maintained in the animal house at Flinders 
Medical Centre (Adelaide, Australia). 
For in vitro T  cell proliferation assays mice were ~mmumzed 
subcutaneously in the tad base and in one hind footpad with 20 tiM 
La peptides  or 100 txg either 6xHis-hLa,  6xHls-mLa fusion pro- 
terns, or baculovirus hLa protein in each site. The antigens were 
emulsified  1:1 in CFA containing Mycobacterium tuberculosis strain 
H37R_a (Difco Laboratories,  Detroit, MI). For analysis of T  cell 
reactivity, pophteal and inguinal lymph nodes were removed and 
recovered cells were pooled 9-10 d after the initial challenge. 
For assessment of antibody responses,  mice were immunized 
subcutaneously  m the tail base with 20 IxM La peptides or 100 txg 
6xHls-La fusion proteins emulsified  1:1 in CFA. The mice were 
boosted twice at 10-d intervals with 10 tim pepndes or 50 p,g fu- 
sion proteins emulsified 1:1 in IFA, and 3-4 d after, the last boost 
animals were bled. 
Lymph Node Proliferation Assays.  9-10  d  after  immunization, 
unfractionated pophteal  and  inguinal lymph  node  cells were 
pooled and processed  as a single-cell suspension and cultured at 
5  ×  l0  s cells/well in flat-bottom 96 well-plates  in HL-1 serum- 
free medium (Hycore Biomedical Inc., Irvine, CA) supplemented 
with 2 mM glutamine and 5 ×  10  s M 2-ME and 5 tim ofa hLa 
pepnde. For epitope screening, pairs of consecutive pepndes were 
added  to the same wells and tested  m triplicate.  T  cell prolifera- 
tion was measured by the addition of 0.5  IxCi of [JH]thymldme 
(ICN, Costa Mesa, Irvme, CA) for the last 18 h of 96-h cultures, 
and thymldine incorporation was measured using a multldetector 
direct  beta  counter system  (Matrix  9600;  Packard  Instrument 
Co., Menden, CT). The stimulation index (SI) was calculated as 
the ratio of cpm measured  in the presence  vs. absence of specific 
antigen. 
In some experiments,  before setting up the proliferation assay, 
lymph node T  cells were purified by passing the cell suspensions 
through a nylon wool column (31). The T-enr,  ched lymph node 
cells (2 ×  10S/well) were then cultured with irradiated syngenelc 
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presence of either protein antigens, pepndes, purified protein de- 
rivative (PPD;  Commonwealth Serum Laboratories,  Melbourne, 
Australia), Con A or medium alone. These assays were performed 
as for unfracnonated LN cells, except that cells were cultured in 
complete DMEM medium (DMEM medium supplemented with 
10% FCS, 2 mM glutarmne, 1 mM Hepes, 5  ×  10  s M 2-ME, 1 
mM pyruvate, and 1 mM nonessential amino acids). 
Generation of T Cell Hybridomas.  The  I-Ak-restncted,  hLa-spe- 
clfic T hybndoma 11B1 was generated by lmmumzing A/J mice 
with 6xHls-hLa (100 btg) emulsified m CFA and fusing the acti- 
vated T  blasts  (32) from the  draining lymph node cells to  the 
TCR-neganve, HGPR.T-negative AKR, thymoma line BW5147 
(32, 33). 
For preparation  ofT cell blasts, the immune LN cells (4 ×  lffV 
ml per well) were restlmulated for 4 d in 24-well plates (Costar, 
Cambridge, MA)  containing 6xHls-hLa (100 Izg/ml)  in 2 ml of 
complete ILPMI 1640  medium (supplemented with  10% FCS, 
2 mM glutanfine, 1 mM Hepes,  and 5 ×  10 -5 M 2-ME). Viable 
cells enriched for T blasts were isolated on Flcoll-Hypaque gradi- 
ents,  and 5  ×  107 cells were fused with BW5147  (107 cells) in 
42%  polyethylene glycol  (tool  wt  =  1,500;  BDH  Chemicals, 
Poole, England) and 15% DMSO. Cells (1  ml) were then plated 
in 24-well plates (105 cells/well) with A/J splenic feeder cells 
(2 ×  10  s cells/well) in a total volume of 2 ml complete RPMI 1640. 
HAT medium (complete  RPMI containing 1.1  ×  10  4 M  hy- 
poxanthine, 1.6 ×  10 -5 M thymldine, and 4 ×  10  v M ammop- 
terin) and the medium (complete  RPMI-HAT) was changed ev- 
ery 3 d. Hybrid growth was first observed at ~10 d after fusion. 
After "~3 wks, cells were transferred  to new plates and gradually 
adapted  to medium containing HT (complete lkPMI plus  1.1  × 
10 -4 M  hypoxanthine and  1.6  ×  10 -~  M  thymidine). Hybrids 
were screened for specificity and then cloned by limiting dilution. 
The representative  T cell hybridoma 11B 1 was studied in further 
detail. 
T Cell Hybridoma Antigen Presentation Assays.  T  hybridomas 
(10S/well)  and either A/J  spleen cells  (2  ×  10S/well)  or  I-A  k- 
transfected  L cells (LIA; 5  ×  104/well) were cocultured for 24 h 
in  flat-bottom 96-well  plates  (Greiner Labortechnik,  Fricken- 
hausen, Germany) in the presence or absence of graded amounts 
of recombinant protein or pepnde antigens.  Cells were cultured 
in complete ILPMI  1640. Recognition of antigen by T hybndo- 
mas results in their activation and production of IL-2. After 24 h 
the culture supernatants  were harvested,  freeze-thawed,  and then 
added (25% vol/vol) to the IL-2-dependent cell line CTLL (34; 
3.5  ×  104/ml, 200  ~l/well, final). Quantitation of IL-2 produc- 
tion was  measured by  [3H]thymidme  incorporation (0.5 IxCi/ 
well) in triplicate samples. 
T Cell Antagonism Aassays.  For assays of T  cell  antagonism, 
LIA (10S/well) or spleen cells from A/J mice (2 ×  10S/well) were 
incubated with a nonsaturating concentration of hLa2ss_302 peptide 
(100 riM) or 6xHis-hLa protein (4 p~M) for 2 h at 37°C. The free 
antigen was removed and APC were washed once before further 
culture  with  graded  amounts  of either  mLa287_3m peptide  or 
6xHls-mLa protein. After 2 h, cells were washed once before the 
addition of the hLa-specific  T  cell  hybridoma 11B1 (105 cells/ 
well).  The supernatants  were harvested  24 h  later  and were as- 
sayed in tnphcate for IL-2 content by [3H]thymMme incorpora- 
tion of CTLL. 
Western Blotting.  P,,ecombmant  anngens and control proteins 
were separated through 12.5% SDS-PAGE and electrotransferred 
to Hybond C extra nitrocellulose membranes (Amersham, Buck- 
inghamshlre, UK). The membranes were blocked with 3% skim 
milk in PBS (wt/vol) for 1 h and then incubated for 1 h with the 
relevant sera (1:250 or 1:500 dilunon). After 3 ×  10 min washes 
in 3% skim milk In PBS, the membranes were incubated for an- 
other 1 h with a 1:1,000 dilunon of horseradish  peroxidase-con- 
jugated  goat  anti-mouse  IgG  (Sigma  Immunochemicals,  St. 
Lores, MO). After a further three washes in buffer, the bound an- 
tibodies  were detected by enhanced chemiluminescence (Amer- 
sham, Intemanonal, Buckinghamshire, UK). 
Antibody Estimations by ELISA.  Recombinant  protein  was 
coated on to Maxlsorp  mlcronter plates (Nunc, R.oskilde, Den- 
mark) by incubating 200 ~1 of protein at 5 btg/ml m 0.03 M car- 
bonate  buffer  at  pH  9.6  overnight  at  4°C.  The  plates  were 
blocked for 1 h at 37°C and incubated with mouse serum diluted 
m PBS buffer containing  0.2% BSA and 0.05% Tween 20 for 2 h 
at 37°C. After washing in 0.05%  Tween 20  in PBS,  the plates 
were  incubated with  an  alkaline  phosphatase-conjugated goat 
ann-mouse IgG (Pierce) for another 2 h. Bound antibodies were 
detected by hydrolysis  of the p-nitrophenyl phosphate  substrate, 
and the developed color was measured at OD 405 nm. 
Results 
Immunization  u,ith Recombinant La Protein blduces Autoan- 
tibodies and Proliferative T  Cell Responses  to both hLa and mLa 
Antigen in Normal Mice.  We  have  previously shown  that 
immunization of normal healthy  mice  with  recombinant 
mLa or hLa protein induced isotype-switched autoantibody 
production,  suggesting T  helper  dependence  of the  im- 
mune response (data not shown and reference 6).  The au- 
toimmune response towards La is also associated with the 
development of autoantibodies to  the  Ro  60-kD  antigen 
occurring 14-20  d  after immunization (6).  Immunization 
with either mLa or hLa induced ann-La autoantibodies, in- 
dicating that T  helper determinants were present in La pro- 
telns from both species. Moreover, the hLa and mLa amino 
acid sequences are 77% identical (30), suggesting that shared T 
epitopes might exist in these homologous proteins. How- 
ever, the magnitude of the induced autoantibody response 
was consistently greater in mice that were challenged with 
hLa compared to those challenged with mLa (6),  implying 
the presence of additional T  helper determinants (xenoge- 
neic epitopes)  in hLa and providing enhanced T  help for 
the  B  cell response.  To  confirm that  immunity to  the La 
proteins was associated with specific T  cell responses, normal 
mice were immunized with recombinant hLa protein, and 
9 d  later,  responding lymph node T  cells were  examined 
for their specificity in vitro. Lymph node T  cells from im- 
munized  mice  specifically  responded  to  6xHis-hLa  and 
6xHis-mLa, but not to 6xHis-DHFP,. or recombinant GST 
protein (Fig. 1 A). The observation that T  cells responded 
to both mLa and hLa confirmed the presence of shared or 
cross-reactive T  cell epltopes present within these antigens 
(Fig. 1 A). Multiple T  cell epitopes were apparently present 
in hLa,  since La subfragments containing GST-hLaA (hLa 
amino acids 1-107) and GST-hLaC (hLa amino acids 111- 
243) also stimulated hLa-primed lymph node T cells. (Fig. 1 
A). The presence of T  cell autoepitopes in mLa was further 
verified by immunizing mice with 6xHis-mLa and examin- 
ing the  response  of lymph node  T  cells  to  either  6xHis- 
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Figure 1.  Proliferative  response ofmunne lymph node T  cells after immunization with recombinant hLa or mLa antigen. (A) A/J mice were immu- 
nized subcutaneously m the hind footpad and at the tallbase with 100 Ixg of 6xHls-hLa m CFA. The draining LN cells were pooled 9 d later,  and the 
T-enriched population was cocuhured (2  ×  10S/well)  In triplicate  with irradiated  (2,000  rads) syngeneic spleen  cells (4 ×  10S/well) in the absence (me- 
dium) or presence of the indicated  recombinant antigens at a concentration of 100 p~g/ml. After a 72-h coculture, the wells were pulsed for 18 h with 
[3H]thymldlne  and then harvested for measurement of incorporated radmactivity.  (B and C) Draining LN cells from A/J mice Immunized with 100/xg of 
6xHIs-mLa in CFA were pooled, and the T-enriched ceils were cocultured with lrra&ated  syngeneic spleen cells an the absence  or presence of graded 
amounts of either (/3) 6xHis-mLa, 6xHis-hLa, or 6xHls-DHF1L (mouse &hydrofolate reductase),  or (C) GST-mLa, GST-hLa, or GST. Data are plotted 
as the mean +SD oftraphcate cultures.  Controls not shown included 100/×g/rot PPD (16,835 -+ 40 cpm) and 1 Ixg/ml Con A (32,919 _+ 29 cpm) in A, and 
100 Ixg/ml PPD (25,400  _+  190 cpm) and 1 Ixg/ml Con A (30,190  +  110 cpm) an (B and C). 
mLa, 6xHis-hLa, GST-mLa, or GST-hLa proteins 9 d later 
(Fig.i, B and C). The results confirmed the presence ofau- 
toreactive T  cells that responded in a dose-dependent man- 
ner to the 6xHis and GST forms of recombinant mLa pro- 
tein  (Fig.  1,  B and  C).  Notably, in mice immunized with 
mLa,  the  in  vitro  T  cell  response  upon  subsequent  chal- 
lenge with mLa was sometimes (Fig.  1,  B  and  C) but not 
always (data not shown) greater than the response observed 
after rechallenge with hLa. This observation suggested that 
mLa may also  contain unique  autodeterminants  not found 
in hLa and which might contribute to the experimental au- 
toimmunity induced by immunizing with mLa. It was also 
noted that responding T  cells reacted to the GST-La fusion 
proteins  with  a  dose  dependence  different  from that  ob- 
served for the 6xHis-La proteins implying that the covalent 
presence of the GST domain (mol mass "°26 KD) may alter 
the efficiency with which GST-La proteins are processed. 
The Specificity of the Murine  T  Cell Response to hLa Includes 
Xeno-andAutodeterminams.  In  nmnerous  experiments,  we 
noticed  that  the  T  cell  response  to  hLa immunogen  was 
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Figure  2.  Peptlde  inapplng of 
the munne T  cell response to re- 
combinant  hLa.  LN  cells  from 
A/J mice nnmunized once in the 
footpad with 6xHis-hLa antigen 
(100  I~g; six  experiments)  or 
baculovlrus  hLa  (100  Ixg; two 
expenments)  in  CFA  were 
pooled  10  d  later  and tested  for 
their in vitro reactivity  against  a 
panel  of 15-mer  peptldes  span- 
ning the complete hLa molecule. 
The result  of one expenment af- 
ter  challenge  with  baculovlrus 
hLa is shown here. Peptldes  cor- 
responding  to  residues  1-294 
contained  a  3-aa  shlR  or  12-aa 
overlap  (i.e.,  1-15,  4-18,  etc.). 
Peptides  corresponding  to  resi- 
dues  282-408  contained  a  2-aa 
shift or 13 aa overlap (1.e., 282-296,  284-298, etc.).  For epitope screening,  peptides were pooled in pairs with the posmon of the anaino temnnus of the 
first peptlde of every second pair shown on the x-axis (i.e.,  1 corresponds to 1-15 and 4-18;  13 corresponds to 13-27 and 16-30, etc.).  Tnphcate LN 
cell cultures (5 X 10S/well) were cultured in HL-1 mechum (Hycore)  contaimng 5 poM (final) of each of the relevant peptldes  Proliferative  data are shown 
as the SI  The average  SI of control non-La peptldes was ~<l. An SI />2 was considered posmve ifa clustered  response (/>2 adjacent  pepude pairs) oc- 
curred in one or more expenment. The amino acid residues  of positive responses obtained in all expenments are shown above the relevant pepndes. The 
dashed hne corresponds to an SI of  2 
1860  Hierarchical Tolerance and Systemic Autoimmumty Table  1.  H-2~-restricted  T  Cell Determinants within hLa 
Comparison of hLa peptide sequence 
and homologous mLa sequence* 
Nature of  Predicted amino  Positive~ 
determmanff  acid residues  experiments 
h  LEAKI CHQIEYYFGDFNL 
m 
h  FGDFNLPRDKFLKEQIKLDE 
m 
h  DEGWVPLE  IMIKFNRLNRLTTDFN 
m  T 
h  LTTDFNVIVEALSKSKAELME  I  S  E 
m  Q .......  K- - -V-A 
h  NDVKNRSVYIKGFPTDATLDD  IKE 
m 
h  RKQNKVEAKLRAKQEQEAKQKLEE 
m  -N  ....  H-GRH-PGM 
h  TCREDLHILFSNHGEIKWIDFVRG 
m  ....... F  V--A-- 
h  DANNGNLQLRNKEVT 
mN  ...... L ....  K-- 
h  SGKGKVQFQGKKTKFASDDEH 
m  RRFKGKGKGNRPGYAGAPKGR 
h  TKFASDDEHDEHDENGATGPV 
m  GYAGAPKGRGQFHGRRTRFDD 
AUTO  13-3{3  6/8 
AUTO  25-44  3/8 
XENO  43-66  3/8 
XENO  61-84  6/8 
AUTO  106-129  4/8 
XENO  196-219  i/8 
XENO  244-267  1/8 
XENO  288-302  8/8 
XENO  350-370  1/2 
XENO  362-382  1/2 
*The predicted mmlmum pepnde epitopes are shown In bold type. A single ammo acid deletion in the mLa sequence corresponding to hLa residue 
217 and a 16-residue insertion in mLa after position 332 alters the numbenng between equivalent mLa and hLa peptides after these posinons (30). 
*AUTO, determinant of hLa where the same sequence is present in mLa; XENO, determinant sequences that differ between hLa and mLa. The 
hLa~,t_84 and hLae~u_30a pepndes were defined as immunodommant, based on the magnitude (SI generally i>6) and frequency of their reacnvtty. Al- 
though hLa13_3, was reactive ~n six to eight experiments, the magnitude of these responses was consistently margnnal (SI ¢'-'2), so this determinant was 
defined as subdommant. 
Positive proliferative T cell responses are defined as an SI i>2 present in two or more adjacent pairs ofpepndes and occumng m one or more exper- 
iment 
consistently  higher,  and  that  it  occurred  at  lower  concen- 
trations  of hLa  protein  than  the  analogous  responses  that 
occur after immunization with mLa (data not shown). This 
observation  was  consistent  with  the  differential  pattern  of 
autoantibody production  after immunizanon with  the two 
forms  of La  protein  (hLa  >mLa;  6).  These  findings  sug- 
gested that in addition to determinants shared between hLa 
and  mLa,  xenogeneic  T  cell  determinants  present  in  hLa 
antigen  might  render  this  protein  more  immunogenic  in 
m~ce  than  autologous  mLa.  Moreover,  we  reasoned  that 
immunodominant  regions  of La  may be  easily  revealed in 
hLa,  but  may be  potentially  tolerogenic  and  therefore  in- 
visible in mLa (12).  To test this hypothes~s, we mapped the 
mouse T  cell response to hLa antigen.  Lymph node T  cells 
were  isolated  9  d  after immunization  with  6xHis-hLa  and 
tested  for  reactivity  with  a  panel  of 155  overlapping  pep- 
tides  spanning  the  complete  hLa  molecule.  Peptides  were 
pooled as pairs of t5 mers overlapping by two or three res- 
idues  w~th  the  next  peptide.  A  summary  of these  experi- 
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ments  is  shown  in  Table  1,  and  the  actual  data  from  one 
such  experiment  is  given  in  Fig.  2.  Two  determinants, 
hLa288_31,2  (core  amino  acids  289-299)  and  hLa61_84 (core 
amino  acids  67-78),  dominated  the  T  cell  response  to  the 
hLa antigen.  Maximal proliferation was always observed to 
the  hLa288_302 peptide,  which  was  stimulatory  in  eight  out 
of eight experiments,  while hLac,  t_84 stimulated strongly in 
six  out  of  eight  experiments.  The  core  amino  acid  se- 
quence  of both  epitopes  revealed  that  they were  xenoge- 
neic  determinants  differing from the homologous mLa de- 
terminants by a single residue (hLa295Q---)mLa294L)  in the 
case ofhLa2~9_299 (mouse homologue  =  mLa288_298) and two 
residues (hLa70E-+mLa70Q and hLa78E--->mLa78K)  in the 
case of La67_78 (mouse homologue  =  mLa67_78; Table  1). At 
least  five  other xenogeneic  hLa  determinants  were  identi- 
fied as defined by clustering of the relevant T  cell response 
to involve two or more pairs of overlapping peptides with a 
SI  i>2  in  one or more  experiment.  However,  a  feature  of 
the  responses  to  these  additional  xenogeneic  determinants 30" 
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Figure  3.  MHC  class II-restncted presentanon of 
the  homologous  hLa2~_302 and  mLa2s  7 ~(n  detemai- 
nants  The T hybnd 11BI was generated from lymph 
node T  cells of A/J mice lmmumzed with recombi- 
nant  6xHis-hLa  and  fused  with  the  thymoma, 
BW5147 (o~-~). The T  hybndoma 11B1 response 
to (.4) synthetic peptides compnslng either hLa288_3.  2 
(dosed symbols) or mLa287_3o  I (open s),mbols), or (/3) re- 
combinant antigen 6xHis-hLa (dosed symbols), 6xHls- 
mLa (opcn symbols) was assayed on H-2  k splenic APC 
(triangles),  or LIA  (arcles). Binding of the hLaeHx_~l,2 
and mLa2,v_3.1 peptides to I-A  k was demonstrated in a 
competitive inhibition assay (C)  Thus, graded con- 
centrations of the synthetic peptides  hLa288 I0e (~) or 
mLaeu7 3<  (D) were incubated with LIA APC m the 
presence  of  a  nonsaturatmg  concentranon  of  the 
HEL46_(, I peptlde  (10  nM)  for  18  h  at 37°C.  After 
washing out the free  peptides,  the competmve dis- 
placement of HEL4e  , ~,1 was assayed by measunng In- 
hibition of IL-2 production by the I-Ak-restncted. HELa6_61-specific T hybndoma 3A9. Each point represents  the mean value of mphcate assays, and the 
experiment was repeated three umes  Functional presentation of mLa2u  v 3~1 was revealed  by demonstrating speofic antagonism of the 1 IB1  response to 
hLa2ss 3.2 by the mLa2sv_3,,1 detemunant after preloading APC with a nonsaturatmg amount of (D) synthetic hLa28  x 3.2 peptide (100 nM) for 2 h before 
the addition of graded amounts of rather mLae.7_~.l ([[]) or the irrelevant l-Ak-bmdmg peptide HEL4~  , ~,, (O).  (E) APC were preloaded with a fixed, non- 
saturating amount of 6xHls-hLa protein (4 bLM) for 2 h befbre the addmon of graded amounts of 6xHls-mLa protein ([1) or control protein HEL (O) 
APC were then incubated for another 2 h and subsequent activation of 11B 1 was measured as IL-2 production  The maxmmm responses (1 ()()%) of 11 B 1 
to the fixed amount of either hLa2~  ~ 3,2 (added to LIA APC) or 6xHls-hLa protein (added to splenic APC) were 5.500 and 6,2i,1 cpm, respecnvely  Each 
point represents  the mean value of tnphcate assays, and the entire assay was repeated three times.  The dashed hnes in D and E represent the esmnated 
lCs0 values for mLa2s7 ~.l and 6xHis-mLa m thelr antagonism of the 11B1 T hybndoma response to the hLa2ss_~e determinant 
was the generally low level ofT  cell stimulation (SI  =  2-6) 
and  the  failure  to  stimulate  T  cells  in  every  experiment, 
consistent with the determinants being either subdominant 
or facultanvely cryptic  (35). 
In addition to  these xenoresponses,  significant T  cell re- 
activity was  identified towards  three hLa peptide  determi- 
nants containing identical amino acid sequences to the ho- 
mologous  peptide  regions  of mLa.  These  "autoepltopes" 
corresponded to peptides in common  with hLa and mLa at 
amino acid residues  13-30  (reactivity in six out of eight ex- 
periments),  25-44  (reactivity in three  out  of eight experi- 
ments), and 106-129  (reactivity in four out of eight exper- 
iments).  In  the  experiment  shown  in  Fig.  2,  the  La25_44 
determinant did not stimulate hLa-primed  T  ceils.  Indeed, 
each  autodeterminant  behaved  as  cryptic  or  subdominant 
epitopes  in  that  they  produced  only  low  levels  of T  cell 
proliferation,  and  in  some  experiments,  they  were  non- 
stimulatory.  Taken  together,  these  findings  confirmed  the 
suspicion  that hLa  and mLa protein  contained shared,  no- 
tionally autologous  T  cell epitopes  in addition  to  xenoge- 
neic  hLa  determinants  recognized  by  the  murlne  immune 
system. 
Efficient  I-Ak-restricted  Presentation  of  the  hLa2a8_302 and 
mLa28~30, Determinants.  The  dominant  hLa  determinant 
hLae88_3(,  2  contained  a  single  species  polymorphism  within 
the core residues La289 299 when  compared with the homol- 
ogous  sequence  La288_298 present  in  mLa  (note  that  mLa 
contains a  single amino acid deletion at the position corre- 
sponding to hLa amino acid 217;  see Table  1).  This obser- 
vation  suggested  that  the  immunodomlnance  of hLa28~_3. 2 
depended on its xenogeneic sequence,  and that the equiva- 
lent  determinant  in  mLa  might  be  tolerogenic  in  normal 
mice. Therefore, we examined the clonal specificity ofT  cells 
responding to the donfinant hLa288 3o2 determinant to eval- 
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lent mLa peptide (non self-tolerant) or whether they were 
hLa specific  (putatively self-tolerant). After immunization 
with hLa protein, CD4-positive T  cell hybrid clones were 
generated from the responding lymph node cells and ana- 
lyzed for  their  peptide  specificity.  One  such  hybridoma 
clone (11B1) gave a strong in vitro response to the hLa288_302 
peptide, and the pattern of reactivity with four overlapping 
peptides spanning this region identified the minimal epitope 
as hLa289_299  (data not shown). This finding verified the pres- 
ence of  mouse T cells recognizing hLa288_302 in the bulk T cell 
responses shown in Fig. 2. 
Notably, 11B1 did not respond to the autologous mLa28  v 301 
(or  mLa288_29s)  peptide,  except at high peptide concentra- 
tions using the I-Ak-transfected L cell APC, (LIA; Fig.  3 A 
and data not shown). The T  hybridoma 11B1  also secreted 
IL-2 in response to intact hLa, but not to mLa protein (Fig. 
3 B). The species specificity of 11B1  for hLa288_302  was  ob- 
served with splenic APC  and LIA (Fig.  3, A  and/3).  The 
nonresponsiveness of 11B1  to mLa287_301 was not the result 
of defective presentation or crypticlty of mLa2s7_301 for sev- 
eral reasons.  First,  mLa2s7 .m~  was  able  to  bind  I-A  k with 
equivalent efficiency to hLa2as_302 based on the comparable 
ability  of these  two  peptides  to  compete with  the  I-A  k- 
restricted recognition ofa HEL46 ~,1 peptide (Fig. 3 C). Sec- 
ond,  the  mLa287_301  peptide behaved as an altered peptide 
ligand (36,  37) for the T  hybridoma 11B1. Altered peptide 
ligands  characteristically contain a single amino acid substi- 
tution from the  parent peptide  and  can block T  cell re- 
sponses even when present in concentrations too low to be 
explained by competitive displacement of the parent (ago- 
nist) peptlde (36, 37). In the experiment shown in Fig. 3 D, 
APC were preloaded with a fixed concentration ofhLa28s_302 
(100 nM),  washed free of agonist peptide, and then incu- 
bated with  increasing concentrations of mLa287_301  before 
assaying  antigen presentation to 11B1. Specific antagonism 
of the  11B1  response occurred at a 50% inhibitory antago- 
nist (mLa287_301)/agonist (hLa288_3(,2) ratio of~10 -~ (Fig.  3 
D). When the I-Ak-restricted determinant HEL46_61  was ti- 
tered into the Ag presentation assay under the same condi- 
tions, there was no evidence of specific T  hybridoma an- 
tagonism,  and  only modest competitive inhibition of the 
11B1  response was  observed at a higher concentration of 
HEL46_61  (Fig. 3 D). Antagonism of the 11B1  response was 
also  observed using  the  minimal  determinants  mLa288_298 
and hLa289_299 as antagonist and agonist peptides  (data  not 
shown),  indicating that the  11B1  response was  dependent 
on  position  294L-->295Q  (mLa-+hLa).  This  observation 
confirms that  the  antagonist properties of mLa2u8 298  arise 
from this single  amino acid substitution, creating an altered 
peptide hgand for the hybridoma 11B1. At high concentra- 
tions  of  mLa287_3m ,  some  agonist  activity  was  observed 
when using the L cell transfectants  (Fig. 3 A), which express 
higher levels of I-A  k than splenic APC (data not shown). 
The 1 1B1 response to intact hLa was also antagonized in 
the presence of very low ratios of intact mLa/hLa antigen 
(50% inhibitory antagonist/agonist ratio of 0.5-1  ×  10-3), 
indicating efficient processing of the La autoantigen result- 
ing  in  presentation  of peptides  containing  the  mta288_298 
determinant (Fig.  3 E). Under the same conditions where 
APC  were prepulsed with  a fixed stimulatory amount of 
intact 6xHis-hLa, titration of increasing amounts  of HEL 
into  the  Ag  presentation  assay  resulted  in  only  modest 
competitive  inhibition  of the  11Bl  response  (Fig.  3  E). 
Notably,  HEL  contains  mutiple  I-Ak-restricted  determi- 
nants  that  are  capable  of  competitive  displacement  of 
hLa2~8_302  (38) emphasizing the potent antagonist properties 
of the  naturally presented mLa288__,g8 determinant derived 
from mLa protein. 
Cellular mLa is probably not presented through an en- 
dogenous pathway because its nuclear localization and low 
abundance render it inaccessible to the endosomal class II 
antigen presentation pathway (39, 40). Moreover, a human 
cell line expressing I-A  k did not constitutively present the 
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Figure  4.  hnmune  tolerance  to 
the nlta2sT_301 determinant in normal 
nnce. A/J mice  (12 per group) were 
immunized  subcutaneously  in  the 
hind footpad and at the tallbase with 
20 vtM ofhLa28s 3(,2 (O) or nlLae~7_~m 
peptlde  (O)  in  CFA.  The  prohfera- 
non  of T-enriched  LN  cells  from 
hLa-  or mLa-prlmed  A/J  nuce  was 
assayed 9 d later by coculture with ]r- 
ra&ated syngenelc spleen cells (2,(100 
rads)  m  the  presence  of  graded 
amounts of either (A) hLa2ss 3(,2 pep- 
tide  (O)  or  mLa287 3,,  peptlde  ((7), 
or (B)  recombinant 6xH]s-hLa anti- 
gen  (C)) or recombinant 6xH]s-mLa 
antigen (V1). There was no T  cell re- 
activity  to  HEL46 61  peptide  (i)  or 
HEL  protein  (A;  SI  =  1)  The  SI 
shown represents the mean value of 
replicate  assays  The  whole  experi- 
ment was carried out twice. endogenous  hLa288_302 determinant,  but  could present  ex- 
ogenous  native  and  recombinant  hLa  antigen  (data  not 
shown). These observations are likely to explain why 11B1 
responses to hLa are not constitutively antagonized by en- 
dogenous mLa antigen present in murine APC. 
As in the case ofmLa287_301 peptide  (Fig. 3, A  and D), at 
high  concentrations  the  intact  mLa  antigen  (Fig.  3  E) 
showed some  agonist  activity by paradoxically stimulating 
the 11B1 hybridoma incubated with APC preloaded with a 
fixed amount of hLa288_302 peptide  or hLa protein  antigen. 
Agonism induced by high concentrations of antagonist de- 
terminants is acknowledged in many systems where altered 
peptide hgands are recognized by the responding T  cell (36, 
37).  Taken  together,  these  data  confirmed  that  mLa287_3< 
was  processed  and  presented  by APC  loaded  with  intact 
mLa antigen, and was readily recognized by specific T  cells, 
even  at low  concentrations  of exogenous  antigen,  consis- 
tent with this peptide being an immunodominant mLa de- 
terminant. 
T  Cell  Tolerance to the Dominant mLa287_3o ! Determinant  in 
Normal Mice.  The presentation  of the mLa2s7_30~ determi- 
nant after antigen processing and the immunodominance of 
the  homologous hLa2ss_302 determinant  suggested  that  the 
mLa28v_301 region  might  be  highly  tolerogenic  in  normal 
mice.  To test whether  this  was the case, groups of normal 
H-2  a mice (I-A  k) were immunized with either hLaess_302 or 
mLa287_301 in  Freund's  adjuvant,  and  draining lymph node 
T  cells were tested for proliferative reactivity 9 d later. T  cells 
from  mice  primed  with  the  hLa288_302 determinant  re- 
sponded  vigorously to  this  peptide  (50%  max  response  at 
"-'20 nM;  Fig.  4  A),  and the  response  was recalled  on the 
intact hLa antigen (Fig. 4  B). In contrast, T  cells  from mice 
primed with mLa2s  7 3,1 proliferated poorly to the mLa287_3o  1 
peptide,  even at high concentrations (50% max response at 
~1  raM; Fig. 4 A), and failed to respond at all to the intact 
mLa antigen (Fig. 4  B). 
As  shown  in  Fig.  3,  the  lack  of T  cell  reactivity  to 
mLa287_301 was not caused by a failure  to bind I-A  k or by a 
lack of presentation of this determinant from intact antigen. 
However, it was possible that the mLa287 3,1  peptide  might 
have  induced  autoreactive  T  helper  cells  that  proliferated 
poorly  despite  providing  functional  cytokine  support  for 
specific  autoantibody  responses.  Therefore,  we  also  tested 
the sera of animals  immunized with  mLa287_30  t peptide  for 
the development ofanti-La antibodies. Neither the rnLa287_31)l 
nor  the  hLae8s_302 peptldes  provoked  an  autoantibody  re- 
sponse  under  conditions  where  immunization  with  intact 
6xHis-rnLa induced a significant antl-La response (Fig.  5 A). 
Notably,  immunization  with  hLa288_302 induces  a  vigorous 
proliferative  T  cell response  (Fig.  4, A  and/3)  without in- 
ducing  autoreactivity  to  endogenous  murine  La  (Figs.  3 
and  5  A),  again  reflecting  the  lack  of functional  T  cell 
cross-reactivity  between  mLa287_3m and  hLa28s_3112 in  the 
murine  T  cell responses.  Presumably,  the lack of autoanti- 
body production despite efficient T  immunity to hLa28s_302 
reflects  the  absence  of B  epitopes  in  this  peptide  and  the 
failure  of reactive  T  helper  cells  to  recognize  the  mouse 
homologue of this  determinant.  Therefore,  we concluded 
that  the  T  cell  repertoire  in  normal  mice  was  specifically 
tolerant of the mLa287_301 determinant,  presumably because 
of its efficient presentation to the T  cell compartment rela- 
tive to other determinants.  Hence, we inferred that the in- 
duction  of autoimmunity  to  mouse  La  protein  (Fig.  5  A 
and reference  6)  was likely to depend on T  helper cell re- 
sponses that recognize nontolerogenic subdominant mLa de- 
terminants such as the mEal3_30  , mLa2s_44, and mLam6_12,  ) pep- 
tides rather than immunodominant determinants within mLa. 
Induction of T  Cell bnmunity and a Divers~ed Anti-La/Ro 
RNP Autoantibody  Response  by a Nontolerogenic Subdominant 
Determinant  ofmLa.  To test whether  the subdominant  La 
determinants La13_30  , La25_44 and La106q29 could initiate anti-La 
autoantibodies, we immunized groups of normal mice with 
one  or  other  of these  peptides  in  Freund's  adjuvant  and 
boosted the  response  two  to  three  times  during a  4-5  wk 
period.  Sera were then tested by ELISA for the presence of 
autoantibodies  recognizing recombinant La protein.  There 
was no detectable anti-La response after immunization with 
the  mLa106q29 determinant;  however,  both  the  mLa2s_44 
and mLa13_30 peptides induced a significant anti-La autoan- 
tibody response in the majority of immunized animals (Fig. 
5  /3). The  pattern  of responses  to  the  three  subdominant 
peptides  suggested  a  hierarchy  of autoimmune  potential 
among self-peptides  (Fig.  5  B),  perhaps  reflecting their in- 
trinsic tolerogenicity or the nature ofT cell responses associ- 
ated with individual peptides. 
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Figure  5.  Hierarchical lmmunogenicity of munne La determinants m 
normal nnce. Groups of six to mght A/J nuce were mlmunlzed with (A) 
20 b~M of  rather nlLa28v_3.t peptlde (~), hLa2su_~()2  pepnde (m), or 100 )xg 
of 6xHls-mLa protein anngen (F]), or (B) mLa25  44, mLa,~-31,, mLam~_)2,, 
or 6xHms-mLa  m CFA, and then boosted twice at 10-d intervals xwth 10 
bLM of  the corresponding  peptlde or 50 txg of  protein anngen m IFA. 3-4 d 
after the last boost, mnchvmdual  sera were pooled and tested at 1/100 (A), or 
were tested mdlwdually at 1/500 (B) for antHnLa annbody reacnwty by 
ELISA using 6xHls-mLa-coated mmcronter plates. The reacnwty of pre- 
mlmune serum also is shown. The value shown for the 6xHls-mLa track 
m (/3) is denved from a 1/500 dfluuon of pooled sera from six unmune 
mice &fferent to those described above m A 
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Figure  6.  Initiation  and  lntramolecular  diversification  of  antl-La  au- 
tolmmunity  after  lmmumzation  wath  the  subdommant  mLal3_3i j peptide. 
Pooled sera (&luted 1/500) from A/J mice lmnmnized and boosted twice 
with either mLal  ~  3~, (upper  panel) or lnLa2s7 301 peptides (middle  panel) were 
used to ammunoblot baculovlms 6xHls-hLa (Bac hLa), the GST-mLa 
subfragments; GST-LaA (aa 1-107 predicted mol mass ~41 kD); GST- 
LaC (aa 111-242 predicted tool mass ~43 kD); GST-LaF (aa 243-345 
predicted tool mass ~33 kD), GST-LaL2/3 (aa 346-416 pre&cted mol 
mass ~31-33 kD:  19, 20), GST-hLaA  3 (aa 46-107 predicted mol mass 
~30-33 kD) (41); rabbit thymus extract (contammg  several nuclear and 
cytoplasmic antigens, I.e., Sm antigens and La,  Pel-Freez Biologacals, 
Rogers, AR); GST protein (predicted inol mass ~26 kD); and recombi- 
nant GST-mLa (predicted mol wt ~74 kD; 20)  separated on a 12.5% 
SDS-PAGE before electrotransfer. The same proteins were imnmnoblot- 
ted with a rabbit anti-GST annsemm at 1:3,000 (lower  panel). Bound anti- 
bodies were detected by ECL (Amersham) using goat ann-mlgG (Sigma) 
as a second antibody. Molecular masses are shown m kllodaltons Bands 
corresponding to lower molecular  weight  degradation products are seen 
In some lanes. 
Intra- and intermolecular spreading of autoimmunity  to- 
wards  the  different components of autologous subcellular 
particles has previously been described when immunity to 
a single component of the particle is triggered experimen- 
tally (1,  4,  6).  To determine whether similar autoantibody 
spreading could be initiated by immunity to  a  single sub- 
dominant La peptide,  we  further examined the specificity 
of the  autoantlbody response to  mLa13_3~, and mLa2s_44 by 
Western blot analysis. In A/J mice immumzed with ntLa25_44  , 
the autoantibody response was restricted to the La A  sub- 
fragment containing the mL%5 44 peptide ofLa autoantigen 
(data not shown). By contrast, pooled sera from m~ce im- 
munized  and  boosted  with  mLal3_30 specifically  reacted 
with recombinant and mammalian sources of intact La anti- 
gen in immunoblots (Fig. 6, upper panel). Moreover, immune 
sera reacted with multiple regions of the mLa polypeptide, 
as shown by immunoblots of La subfragments spanning four 
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Figure 7.  Intermolecular diversification  of the autoantibody response 
to involve Ro autoanngens  after immunization  with the subdominant  de- 
terrmnant mLal3_30 Pooled immune serum (diluted 1/250) from A/J mace 
immumzed with mLa13_3, pepnde was reacted with baculovirus 6xHls- 
hLa  (Bac hLa), 6xHls-mLa, rabbit thymus extract, 6xHls-HEL, 6xHxs- 
DHFR, and 6xHls-hP.o52 (Amrad, Melbourne, Austraha), separated by 
SDS-PAGE and electrotransferred to  nitrocellulose membrane, Bound 
antIbo&es were detected by ECL  (Amersham) using goat ann-mlgG 
(Sigma) as second antibody. Molecular  masses are shown in kxlodaltons. 
nonoverlapping  regions of the mLa molecule, LaA (aa 1-107), 
LaC (aa 111-243), LaF (aa 244-345), and LaL2/3 (aa 346- 
416;  Fig.  6).  In some lanes (e.g.,  Bac.hLa,  Fig.  6,  lane 1), 
immune mouse sera  (upper panel)  and hyperimmune rabbit 
anti-GST serum (Fig. 6,  lower panel)  reacted with multiple 
bands representing proteolytic degradation products of the 
recombinant antigens. Absorption of pooled immune sera 
with one subfragment of La (e.g., the LaC) specifically re- 
moved immunoblot reactivity to that fragment without af- 
fecting binding to the other subfragrnents (data not shown). 
By contrast, absorption with recombinant GST protein had 
no significant effect on the reactivity of the pooled serum 
with La subfragments (data not shown). This finding con- 
firms that reactivity of the immune sera with different re- 
gions of the La polypeptide was not caused by cross-reac- 
tive antibodies. In addition, immunoblot reactivity of the 
immune sera  was  not observed with  the  control proteins 
6xHis-DHFP,, 6xHis-HEL, or with other nuclear proteins 
such as Sm polypeptides known to be present in the rabbit 
thymus extract (Figs.  6 and 7). A component of the anti-La 
response that develops after immunization with mLal3_30 is 
probably directed  towards  the  La13_3a peptide  itself since 
this  peptide  absorbs  some  of the  antibodies directed  to- 
wards  the  LaA  subfragment  that  contains  these  residues 
(data not shown). 
To  determine whether intermolecular spreading of au- 
toimmunity also follows immunization  with mLa13_30  , pooled 
immune serum was  examined for  lmmunoblot reactivity 
with the Ro  (SS-A) autoantlgens (Fig. 7).  The Ro 60-kD 
antigen is known to be associated with the La polypeptide 
in a  snP.NP particle  (42),  and autoantibodies to both Ro 
60-kD and R.o 52-kD antigens are strongly associated with 
anti-La antibodies in systemic autoimmunity (43).  Pooled 
sera from mice immunized with the La13_30 peptide reacted 
specifically with recombinant Ro  52-kD  antigen (Fig.  7); 
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Figure  8.  Immumzatlon with 
the subdomanant pepnde lTtLa13_~l I 
induces a prohferatxve T cell re- 
sponse that is recalled on  intact 
mLa  and  hLa  antigens  CBA 
mice  were  lmmumzed  in  the 
hind footpad and subcutaneously 
at  the  taflbase with  20  b~M 
mLa13 ,¢~ peptlde m  CFA.  9  d 
later,  T-enriched  draining  LN 
cells were tested for thmr speci- 
ficity by assaying  the prohferauve 
response to  irradmted syngenmc 
spleen cells (2,000 rad) loaded ra- 
ther with (A) the pepndes  mLa,  ~_.~. 
lrlta2s_44,  Inta287_3Ol,  or  HgE46_.l, 
or  with  (B)  recombinant  6xHis- 
mLa, 6xHis-hLa, 6xHis-mLaA  (1- 
107 aa), or recombinant 6xHIs- 
DHFIq. as control anngens. Each 
point represents the mean value 
of tnphcate assays. 
however,  reactivity with  recombinant  Ro  60-kD  antigen 
was equivocal and not observed in all experiments (data not 
shown). The titer ofanti-Ro  52-kD antibodies was signifi- 
cantly lower than  that  of the  anti-La response  (1/500  for 
anti-P,.o  52  and  ~<1/3,000  for anti-La antibodies). None- 
theless, this reactivity was specific, since binding to control 
recombinant proteins (6xHis-DHFR and 6xHis-HEL) was 
not observed under the same conditions, (Fig. 7). We con- 
clude  that  immunization  with  the  subdominant  mLa13_30 
peptide is sufficient to induce  intramolecular spreading of 
autoimmunity to La autoantigen,  as well as a low level of 
lntermolecular antibody spreading of the  autoimmune  re- 
sponse. 
The Autoantibody  Response  to  the  mLa13_30 Determinant  Is 
Associated u,ith an Autoreactive  T  Cell Response.  Triggering 
of autoimmunity by immunization with subdominant pep- 
tides such  as the  mLal3_30 peptide was  presumed  to  occur 
through  the  activation of nontolerized T  helper cells that 
recognize this determinant. Therefore, we evaluated whether 
immunization  with  mLa~3_30 peptide induced  specific au- 
toreactive T  cells. CBA/CaI-I mice were immunized with 
mEal3_30 peptide in  adjuvant,  and  draining lymph node  T 
cells were examined for antigen reactivity 9 d later. Immune 
T  cells proliferated specifically in response to mLa13_30, but 
not control peptides mLa25 44, mLaes7_3,1, or HEL46_61 (Fig. 
8 A). These T  cell responses were recalled in the presence 
of recombinant  intact  mLa,  hLa,  and  mLaA  subfragment 
(residues  1-107)  but not the control protein 6xI-Iis-DHFtL 
(Fig. 8 B). Similar results were obtained after immunization 
of A/J  mice  (data  not  shown).  Hence,  the  spreading au- 
tolmmunity  that  follows  immunization  of normal  H-2  k 
mice with the subdominant mLa 13_3. peptide is associated with 
specific T  helper responses recalled on intact mLa antigen. 
Discussion 
Although La is ubiquitously expressed in the nucleus and 
cytoplasm of diverse cell types, there is little data about the 
extent of immune  tolerance that develops to this or many 
other intracellular sequestered self-antigens in normal indi- 
viduals. Indeed, establishing whether the immune system 
is  actively tolerant to  a  given  determinant within  a  self- 
antigen  is  experimentally  difficult  because  of  the  many 
ways in which nonresponsiveness may occur and the need 
to examine the host immune response in the presence and 
absence  of expression  of the  self antigen.  In  the  experi- 
ments reported here, we have immunized mice with a sur- 
rogate self-antigen, vlz., the human La antigen that is 77% 
identical  to  mouse  La  (30).  This  approach  has  allowed 
identification of an  immunodommant  determinant  of hu- 
man  La  (hLaess_302) and  a  homologous  but  tolerogenic 
epitope  derived  from  endogenous  mLa  (mLa287_301). The 
evidence  that  this  determinant  is  tolerogemc  in  mice  is 
based on the lack of either T  cell responses or autoantibod- 
ies after immunization of normal mice with the mLa287_3m 
pepude. The mLa determinant was efficiently presented af- 
ter  antigen  presentation,  as  demonstrated  by  inhibition 
binding studies to I-A  k and specific antagonism of the im- 
munodomlnant  hLa288_302 homologue  by both  intact mLa 
and  the  mLa2s  7 301  peptide that  possessed properties of an 
altered peptide ligand for hLa288_302 recognition. Sercarz has 
cautioned  that  despite antigen presentation  and  immuno- 
dominance of a particular determinant in one species, com- 
parable immunodominance  cannot be assumed for homol- 
ogous determinants across species (15). Nonetheless, in this 
case,  the  hLa2a8_302 and  mLa2~7_3,,1 determinants do  appear 
to be equivalent in their antigen presentation and behave as 
immunodominant peptides in H-2 k and H-2  a mace. 
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nous La polypeptides are indeed processed and presented to 
host T  cells,  presumably by an exogenous pathway involv- 
ing uptake and catabolism of La/Ro RNP  particles.  This 
putative turnover and antigen presentation of endogenous 
P.NPs clearly does not lead to autoimmunity under normal 
conditions.  However, once autoreactive T  cells have been 
primed towards poorly tolerogenic determinants within the 
La/P.o RNP, antigen presentation after the natural uptake 
of these RNPs appears to be potentially autmmmunogenic. 
In our experimental model,  the poorly tolerogenic deter- 
minants  are  presumably subdominant  or might behave as 
facultatively  cryptic  regions  of the  La  molecule  that  are 
only  presented  under  special  circumstances.  Regardless, 
humoral  immunity  to  mLa is  easily triggered  experimen- 
tally and is associated with T  cell responses to subdominant 
determinants. Although our assays have measured prolifera- 
tive  T  cell  responses,  these  responses  are  assocmted with 
functional T  helper cells revealed by the isotype switching 
of associated autoantibody responses. 
The autoreactive T  cell response induced by the mLa13_30 
subdominant  peptide  was  recalled  on  intact  La  antigen, 
even though  T  cell responses to  this  and  other subdomi- 
nant mLa peptides were not  evident in  every experiment 
involving immunization  with  intact  La protein.  This pat- 
tern of autoreactiwty is distinct from the autoimmune T  cell 
responses that recognize cryptic peptides of the snRNP D 
protein described by Bockenstedt et al.  (4).  In that study, 
priming of T  cells with peptides derived from snlLNPs re- 
suited in  only a limited autoantlbody production,  and re- 
sponding T  cells were not stimulated by APC pulsed with 
intact snlKNPs in vitro.  Coimmunization  and boosting of 
normal mice with a mixture of native snlKNPs and cryptic 
pepndes,  however,  induced  spreading of the  anti-snRNP 
antibody response. The diversification of the autoimmune 
response  towards  snRNPs  (4)  presumably occurs through 
selective uptake of the exogenous snlkNPs by different au- 
toreactive B  ceils that then present processed snlKNP anti- 
gen to T  cells  that recognize newly revealed cryptic pep- 
tides. In the experimental autoimmunity we have described 
here,  the  &versification of the  autoimmune  response oc- 
curred without the need for any challenge with exogenous 
intact La/Ro 1KNPs suggesting that the autoimmunization 
driving the spreadmg of the response was caused by endog- 
enous turnover ofintracellular RNPs. 
We propose that under normal conditions, subdominant 
self-determinants are continuously being presented to T  cells 
by APC,  including  self-reacnve B  cells  (44),  but this pre- 
sentanon is qualitatively (45) and quantitatively (46) insuffi- 
cient to prime naive self-reactive T  cells.  In particular, the 
necessary costimulatory signals  are likely to be absent under 
conditions  of  constitutive  antigen  presentation,  and  the 
density of subdominant determinants presented on the sur- 
face of the APC probably falls below the threshold for acti- 
vation of naive T  cells. 
It seems likely that  experimentally induced  autoimmu- 
nity  to  the  La/Iko  RNP  occurs  because  immunization 
overcomes the priming threshold by using larger amounts 
of antigen than is normally encountered in vivo and by us- 
ing  adjuvants  to  activate APC  and  induce  the  qualitative 
costimulatory APC  functions that are necessary for T  cell 
priming (45,  47-52).  In other words,  experimental induc- 
tion of autoimmunity exposes the  extent  of immune self- 
ignorance. 
Experimental autoimmunity to autologous recombinant 
La (6)  and iKo 52-kD antigen  (53)  can be induced by im- 
munization  with  recombinant  autologous  La protein  (6), 
whereas immunization with autologous nanve snRNPs (1, 4), 
cytochrome  c  (17,  18,  54),  histone  preparations  (6,  55), 
nDNA (56),  and P53 antigen (57) all fail to induce high ti- 
ter autoantibody responses in experimental animals. These 
&fferences in the immunogeniclty of lntracellular self-anti- 
gens might reflect degrees of host immune tolerance based 
on antigen abundance, turnover, adjuvanticity, intracellular 
trafficking, or structural  complexity affecting antigen pro- 
cessing. Alternatively, the use of recombinant intact La an- 
tigen may facilitate its processing compared with native La 
antigen.  Notably,  the  recombinant  La was  haghly soluble 
and retained the capacity to bind poly U  1KNA (30),  ATP, 
patient autoantibodies,  and mouse anti-La mAbs, suggest- 
ing that some native structure is maintained by the bacterial 
La antigen.  Nonetheless,  it remains possible that challenge 
wath native La/tLo 1KNP antigens may result in a hierarchy 
of peptide  determinants  different from that observed with 
recombinant proteins. However, this does not alter the ev- 
idence that immunization with peptide determinants nom- 
inally defined as subdominant resulted in a natural spread- 
ing  of autoimmunity  to  involve  multiple  components  of 
the La/1Ko 1KNP. 
We propose that the initial diverslficanon of the autoim- 
mune response is driven by selective constitutive uptake of 
endogenous "native" La/1Ko tLNP complexes by autoreac- 
tive B cells expressing specific mIg (44) leading to presenta- 
tion  of the  same  subdominant  determinants  after antigen 
processing. Thus, T  cells specific for one subdominant de- 
terminant might provide helper signals to distinct autoreac- 
rive  B  cells  with  differing  specificities  within  the  IKNP 
complex. It is also  possible that once the autoimmune re- 
sponse  is  initiated,  natural  presentation  of mulnple  sub- 
dominant (or cryptic) determinants will lead to spreading of 
the T  cell response (7).  Spreading of T  cell autmmmunity 
may  depend  on  priming  by specific  autoreactive  B  cells 
(54),  but could also involve enhanced antigen presentation 
through  FclK  uptake  of autoantibody-autoantigen  com- 
plexes. The relative contribution of these potennal mecha- 
nisms  in  explaining  diversificanon  of the  autoimmune 
response  needs  clarification.  If systemic  autoimmunity 
involving ubiqmtous self-antigens is initiated by T  cell re- 
sponses to one or two subdominant self peptides, then se- 
lecnve antigen presentation might explain HLA class II al- 
lele association with certain antinuclear autoantibodies (58). 
Maintenance of autmmmunity may reqmre chronic  expo- 
sure to an antigenic trigger as well as a genetic predisposi- 
tion  affecting funcnons  such  as  MHC  restriction  of non- 
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or exaggerated cytokine production (60).  Notwithstanding 
these  considerations,  the  mechanism  by  which  particular 
sets  of nuclear  autoantigens  are  selected  in  different  sys- 
temic autoimmune  disorders remains mysterious. Our ob- 
servation here,  which has shown  that complex patterns of 
autoantibody production can be triggered by immunity to 
a single peptide determinant, suggests how limited molecu- 
lar mimicry by exogenous  agents  might  initiate spreading 
of the autoimmune response (61). 
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